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ABSTRACT 
The functions of most genetic circuits require sufficient degrees of cooperativity in the circuit 
components. While mechanisms of cooperativity have been studied most extensively in the 
context of transcriptional initiation control, cooperativity from other processes involved in the 
operation of the circuits can also play important roles. In this study, we examine a simple kinetic 
source of cooperativity stemming from the nonlinear degradation of multimeric proteins. Ample 
experimental evidence suggests that protein subunits can degrade less rapidly when associated in 
multimeric complexes, an effect we refer to as “cooperative stability”. For dimeric transcription 
factors, this effect leads to a concentration-dependence in the degradation rate because 
monomers, which are predominant at low concentrations, will be more rapidly degraded. Thus 
cooperative stability can effectively widen the accessible range of protein levels in vivo. Through 
theoretical analysis of two exemplary genetic circuits in bacteria, we show that such an increased 
range is important for the robust operation of genetic circuits as well as their evolvability. Our 
calculations demonstrate that a few-fold difference between the degradation rate of monomers 
and dimers can already enhance the function of these circuits substantially.  These results suggest 
that cooperative stability needs to be considered explicitly and characterized quantitatively in any 
systematic experimental or theoretical study of gene circuits. 
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It is well known that the expression of genes can be regulated at a number of different stages, 
including transcriptional, translational, and post-translational controls. The predominant focus of 
many experimental and theoretical studies on genetic circuits thus far has been on the 
combinatorial control of transcriptional initiation, which to a large extent determines the 
connectivity of the circuits (1-3). Substantial efforts have also been invested in elucidating the 
regulatory processes that control protein degradation (4). Such processes include the covalent 
modification of one protein by another or the binding of one protein with another, resulting in 
altered turnover rates for the proteins involved (5). One consequence of an altered protein 
turnover rate is a shift in the steady-state cellular concentration of that protein depending on the 
presence/absence of other proteins. Thus, degradation control provides an additional way of 
establishing connections between the genes in genetic circuits. This mode of control is often used 
by cells when the timescale of the response is required to be short. For instance, an increase in 
the degradation rate allows the rapid removal of protein products (6) or conversely, protection 
from degradation provides a rapid way of accumulating the protein (7).  
In this study, we examine an effect of protein degradation that does not involve regulatory 
control but can nevertheless impact the operation of genetic circuits in important ways. It is a 
kinetic, cooperative effect predicated on two essential ingredients: (i) the fact that many proteins 
perform their physiological functions as dimers or higher-order oligomers, and (ii) the tendency 
for the oligomers to be more stable (to proteolysis) than their monomeric components. This 
effect, referred to below as “cooperative stability”, has been discussed previously in qualitative 
terms in the context of many well-studied examples in prokaryotes and eukaryotes; see reviews 
by Gottesman & Maurizi (4) and Jenal & Hennge-Aronis (5). For example, in the SOS response 
of E. coli, UmuC degradation is rescued by oligomerization with UmuD’2 (8). And in S. 
cerevisiae, Johnson et al (9) showed that the dimerization of the mating-type factors a1 and α2 
reduced the degradation rate by as much as 15-fold. Possible molecular mechanisms giving rise 
to cooperative stability include enhanced thermal stability of proteins upon mutual association 
[since thermal instability correlates with the rate of degradation (10,11)], and the burial of 
proteolytic recognition sequences between protein interfaces (9). 
While most of the previous studies of cooperative stability focused on protein complexes 
with heterogeneous protein subunits, we study here its effect for typical transcription factors 
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(TFs) that exert their biological functions only as homodimers (12). If such dimers are intended 
to operate at two concentrations, e.g., a “low” and a “high” concentration, then cooperative 
stability can widen the ratio between the two concentrations in vivo. This is a simple effect due to 
the nonlinear dependence of the protein degradation rate on the concentration, i.e., enhanced 
degradation rate at low concentrations due to the predominance of monomers, or alternatively, 
the enhanced stability of dimers that are predominant at high concentrations. Through theoretical 
analysis of two model gene circuits in bacteria, we will illustrate that cooperative stability can 
significantly enhance the function of these circuits. Specifically, we show that a several-fold 
effect in cooperative stability can make gene circuits more robust to stochastic fluctuations while 
also broadening the basin of parameter space supporting circuit function. The latter enhances the 
evolvability of the circuit. 
 
CIRCUITS AND MODELS  
In this study, we analyze two basic genetic circuits, one that displays bistability and the other 
spontaneous oscillation, two important classes of behavior in biomolecular circuits. The first 
circuit consists of only a single gene with the gene product activating its own transcription, see 
Fig. 1a. This is one of the simplest circuits that can produce two stable states (at LOW and HIGH 
levels of transcriptional activities), as was shown by theoretical analysis and an experimental 
implementation in E. coli (13). The second circuit we analyze consists of three genes connected 
in a ring topology, each repressing the transcription of its downstream partner, see Fig. 1b. 
Elowitz and Leibler (14) have shown both theoretically and experimentally that this 
“repressilator” can spontaneously oscillate.  
Rather than model these circuits in full detail, our goal here is to use these circuits to identify 
generic effects that cooperative stability imparts to their functions. Accordingly, we use simple 
quantitative models and describe each circuit by only a few essential parameters, so that the 
effects of cooperative stability can be characterized. Fig. 2 summarizes the biochemical 
processes considered in our model together with the associated rates. We describe the net change 





= α ⋅ g([TF]) − λm ⋅ m , [1] 
where α denotes the transcription rate of the promoter at full activation, g([TF]) describes the 
promoter activity as a function of the transcription factor concentration [TF] (see Fig. 3), and  






= ν ⋅ m − (λ p1 ⋅ p1 + 2λ p2 ⋅ p2 ) , [2] 
where ν  denotes the translation rate of mRNA. In the turnover term, the total protein 
concentration   is partitioned into monomers and dimers with concentrations 
and , and with turnover rates  and  respectively. Note that the turnover term in Eq. 2 
is linear in p when 
 
, and becomes nonlinear in p with cooperative stability (
 
).  
p = p1 + 2 p2
 p1 p2  
λp1 λp2
λ p1 = λp2 λ p1 > λp2
The protein products involved in our genetic circuits are all transcription factors, and as is 
often the case in bacteria, they function as activators or repressors only in the form of 






with   being the equilibrium dissociation constant.  Kd
Throughout this study, we do not explicitly include the stochastic effects of transcription, 
translation, and dimerization.  Stochastic fluctuations are dominant when the mRNA or protein 
concentrations are low (19-21). Nevertheless, our formulation Eqs. 1-3 ensures (22) that the 
results we obtain correspond to the statistically-averaged results of more complex models that do 
include these stochastic effects. The advantage of our approach is that it allows us to rapidly 
elucidate the average behavior of each circuit for all combinations of its parameters. By 
demanding that the average protein concentrations not be too small, we can identify those 
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(desirable) combinations of parameters for which the circuit behavior is mostly insensitive to 
stochastic effects.  
 
RESULTS 
For each circuit shown in Fig. 1a and 1b, we want to identify the effect of cooperative stability 
on its phenotypic behavior using the quantitative model described above. Towards this end, we 
first determine the parameter regimes where the circuits are operational (i.e. bistable or 
oscillatory) without cooperative stability ( ), and then with cooperative stability 
(
 
). For the latter case, we make the (reasonable) assumption that dimer turnover occurs 
mainly by cell growth/dilution, while monomers can experience accelerated degradation. Thus 
we take the typical half-life of dimers to be of the order of the cell doubling time (~ 50 min for 
bacteria in the exponential growth phase), whereas the typical half-life of monomers can be 
shortened to a few minutes. 
λ p1 = λp2
λ p1 > λ p2
Bistable circuit 
Since this circuit consists of a single gene with positive autoregulation, and only dimers can 
activate transcription, the promoter activity increases with the dimer concentration.  This is 
indicated by the promoter activity function  sketched in Fig. 3a, with[ . For any initial 
mRNA and protein concentration, this circuit will settle into a steady state given by the condition  
gA TF] = p2
 
 
γ ⋅ gA( p2*) = λp1 ⋅ Kd p2 * + 2λp2 ⋅ p2 * [4] 
where   denotes the steady-state dimer concentration and p2 * γ = α ⋅ν λm  is the protein 
synthesis rate of this gene at full activation. Eq. 4 is a simple statement that at steady state, the 
protein synthesis rate (left hand side) must balance the protein degradation rate (right hand side).   
Regime of bistability. Bistability results when Eq. 4 has two stable solutions for , so that the 
gene can settle in either a HIGH or LOW state depending on the initial condition. This property 
p2 *
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is dependent on the parameters γ ,  and the ’s, as well as the shape of the promoter 
activity function g .  The activity function shown in Fig. 3a is characterized by three 
parameters: (i) f, the fold-change in promoter activity between the basal and fully-activated 
levels, (ii) 
Kd λp
A ( p2 )
κ , the TF concentration where the promoter activity begins to saturate, and (iii) n, the 
effective Hill coefficient which characterizes the cooperativity of the promoter activity function; 
see Supporting Information. Among these parameters, κ  andγ  can easily be varied over several 
orders of magnitude via choices of the operator (23) and the ribosomal binding sequences (24) 
respectively (we refer to these parameters as programmable). In contrast, the parameters f, n, 
and  tend to be more constrained physiologically. For example, while there is no intrinsic 
biochemical constraint for   to be small, values around  nM nevertheless appear to be 
typical according to in vitro measurements
Kd
Kd Kd ≈ 10
*, e.g., nM for λCI (25),  nM for Arc 
(26),   nM for NtrC (27), and  nM for Crp (28); however, see footnote in Table 1. 
The physiological range for all of the parameters used in our model is described in Table 1. As 
our goal is to study the circuit behavior for parameters within the typical physiological regime, 
we will analyze the circuit behavior over a wide range of values in 
Kd ≈ 20 Kd ≈ 8
Kd ≈ 10 Kd ≈ 1
κ  andγ , but only for a few 
representative values of  , , and . f n Kd
 The bistability of the circuit depends only on certain combinations of the parameters, see 
Supporting Information. It is revealing to plot the regime of bistability as a function of the 
programmable parameters, using the parameter combinations Kd /κ  and on the x- and 
y-axes, respectively, see Fig. 4a. The remaining parameters are fixed at 
γ / (κ λp2 )
n = 1 and  , 
which corresponds to a strong activator (e.g., Crp) with a single operator site.  
f = 100
Circuit without cooperative stability. For λp1 = λp2 , the corresponding bistable regime is the 
narrow black strip at the lower right corner of Fig.4a. With a given value of , the black region Kd
                                                 
* The effective value of  in vivo is expected to increase with respect to its in vitro value due to dimer turnover. 






 Kd = (kd + λ p 2 ) ka  instead of the usual in vitro expression Kd = kd ka . However, for typical small proteins, this 
increase is estimated to be less than ~ 1 nM and hence not important for this discussion; see Supporting Information. 
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defines an acceptable range of γ  for each value of κ . The circuit behavior within the bistable 
regime is demonstrated in Fig. 4b by plotting the steady-state monomer and dimer concentrations 
(grey and black curves respectively) in the HIGH and the LOW state (solid and dashed lines) as 
a function of κ , using the typical dimer dissociation constant of Kd = 10  nM. Note that the 
steady-state TF concentrations are very low, not exceeding  nM, which corresponds to 
about 10 molecules per bacterial cell. Such low concentrations are difficult to maintain reliably 
in the cell
p2* ~ 10
†, and the circuit will be susceptible to various sources of stochastic fluctuations (40). 
Similar results are obtained using our model with f = 11  and n ≈ 1.7 , which mimics the bistable 
circuit studied experimentally by Isaacs et al (13); see Fig. S2 and S4 in Supporting Information. 
We note that strong fluctuations were indeed observed in that experiment. 
The steady-state protein concentrations could in principle be increased (consequently 
reducing stochastic effects) for larger values of , e.g. Kd Kd = 1000  nM as shown in Fig. 4c. In 
this case, however, the concentrations of the nonfunctional monomers (grey curves) are 
significantly larger than the concentrations of functional dimers (black curves). Indeed, without 
cooperative stability, monomer overproduction is a generic consequence of leveraging 
cooperativity from dimerization since the system can only exploit this source of cooperativity 
when the total protein concentration is much less than  (i.e. when the protein exists primarily 
in monomer form). While the overproduction of monomers may or may not be detrimental to the 
cell for an individual gene, the monomer “load” can become a significant problem if weak 
dimerization is a generic strategy widely adopted by the cell, e.g., if every regulatory gene 
contributes 10 ~100 nonfunctional monomers in the LOW or HIGH states. This observation is a 
conceivable explanation for the small  values found for typical dimeric proteins.  
Kd
Kd
Effect of cooperative stability. The grey and the hatched areas in Fig. 4a show how the bistable 
parameter regime is shifted when cooperative stability is introduced with λp1 λp2 = 3  
and
 
λp1 λp2 = 10 , respectively. For a given value of , cooperative stability leads to a shift in 
the bistable regime towards an increased rate of protein synthesis 
Kd
γ . By increasing the protein 
                                                 
† Vilar & Leibler suggest that with DNA looping it may be possible to reduce this noise even with low numbers of 
molecules (39) 
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concentration, an increased γ  reduces the susceptibility of the bistable circuit to stochastic 
fluctuations. This increase is seen explicitly in Fig. 4d, where we plot again the steady-state 
monomer and dimer concentrations in the HIGH and LOW states with the typical   nM 
as in Fig. 4b, but this time with 10-fold cooperative stability ( ). Comparison of Fig. 
4d to Fig. 4c demonstrates a second beneficial effect of cooperative stability: a significant 
reduction of the monomer load.  
Kd = 10
λp1 = 10 ⋅ λp2
The origin of the beneficial effects of cooperative stability is that it extends the regime of 
protein concentrations where cooperativity is obtained through dimerization from  where 
most of the proteins are monomers, to
p < Kd
p < Kd ⋅ λp1 / λp2( )2 , see Eq. S12 in Supporting 
Information. This results in an effective decrease in the value of  needed for bistability by a 
factor of . The grey and hatched regions in Fig. 4a can be viewed as the black region 
with an appropriate reduction in . Moreover, for the case shown in Fig. 4d with   nM 
and 10-fold cooperative stability, the dimer concentrations (black curves) are identical to those in 
Fig. 4c, which were obtained for   nM and . The same black curve could also 
be obtained for   nM and ~ 3-fold cooperative stability (not shown). Due to this large 
-fold reduction in , we expect a few-fold effect in cooperative stability to exert a 
large impact on circuit function. 
Kd
 
λ p1 / λp2( 2)
)
Kd Kd = 10
Kd = 1000 λ p1 = λp2
Kd = 100
 
λ p1 / λp2( 2 Kd
Three-gene oscillator  
In the repressillator circuit of Fig. 1b, we have 3 genes whose mRNA and protein products, 
and   with , are described by Eqs. 1-3. To focus on the generic behavior of this 
circuit, it is useful to assume that all 3 genes have identical properties, i.e. the same promoter 
structure, synthesis/turnover rates, and dissociation constant  for protein dimerization (14). 
The form of the repressive promoter activity  is shown in Fig.3b, and is characterized again by 
the three parameters  ,
 m( i) p( i) i ∈{1,2,3}
Kd
gR
f κ , and  . We will examine in detail promoters with a single repressive 




Oscillatory regime. The regime of parameter space supporting oscillation is obtained by linear 
stability analysis around the steady-state solution with {  and  { ; see 
Supporting Information for details. Generally, oscillation is favored when (i) the fold-change f is 
large, (ii) the protein and mRNA turnover rates are comparable, and (iii) there is a large 
cooperativity/nonlinearity in synthesis and/or degradation; see also ref. (14).  
dm( i) / dt = 0} dp( i) / dt = 0}
Circuit without cooperative stability.  For , we show in Fig. 5a the oscillatory 
parameter regime for typical (f = 100) and exceptionally strong (f = 1000) repressors, paired with 
either typical (
 
) or rapid ( ) protein turnover. Even for the most favorable 
combination, i.e. 
 
and f = 1000, oscillation is not possible until  >100. Thus, for 
typical  nM and typical κ of 1~1000 nM, this system cannot sustain oscillations. In the 
experiment of Elowitz & Leibler (14), oscillation was obtained by (i) adding ssr-tags to the TFs 
so that they degrade much faster to make the protein and mRNA turnover rates comparable, and 
(ii) using some of the strongest repressive promoters known (30). The latter not only 
makes , but the multiple repressive operator sites (shown in Fig. 1f) increase the value 
of the Hill-like coefficient associated with the transcription initiation to 
λp ≡ λp1 = λp2
λp / λm = 0.1 λp / λm = 1
λp / λm = 1 Kd / κ
Kd ~ 10
f > 1000
n ≈ 1.63 (see Supporting 
Information), thereby further broadening the accessible parameter space. While the solution 
found by Elowitz & Leibler (14) is a triumph of synthetic engineering, we believe that such 
“extreme” solutions will be difficult to find by natural evolution due to the rarity of existing 
circuit components (e.g., promoters and TFs) with such extreme characteristics. The circuit 
would be much more evolvable if oscillation can already occur for typical components, e.g., for 
TFs with  and promoters consisting of a single repressive operator site with λ p / λm : 0.1 f ≤ 100 .  
Effect of cooperative stability. By destabilizing the monomers with respect to the dimer species 
such that (
 
), cooperative stability will have two effects: First, as in the case of the self-
activating one-gene switch, it extends the regime where cooperativity is obtained through 
dimerization from  to
λ p1 > λp2
p < Kd  p < Kd ⋅ λp1 / λp2( )2 , thereby making the oscillatory regime more 
accessible to TFs with smaller . Second, the condition for oscillation favors the monomer 
degradation rate be closer to the mRNA degradation rate; see Supporting Information. For 
Kd
10 
typical gene products with 
 
, a 10-fold effect in cooperative stability puts 
close to unity, thereby further extending the oscillatory regime. This is illustrated in Fig. 
5b, where we specifically plotted the oscillatory regime for  with both 
λ p2 / λm ~ 0.1
 
λp1 / λm
λ p1 = λm = 10λ p2 f = 100  
and . In comparison to the circuit without cooperative stability (Fig. 5a), oscillation is 




Advantages of cooperative stability 
In this study, we examined the function of simple genetic circuits for dimeric TFs with various 
degrees of cooperative stability, i.e., where monomers turnover more rapidly than the functional 
dimers. In the absence of cooperative stability, the desired operation of both the one-gene switch 
and the 3-gene oscillator requires parameters that are on the edge of what is physiologically 
realizable. These limitations can be understood in simple terms: Proper functions of most 
biological circuits require a sufficient degree of cooperativity in the circuit components. 
Cooperativity at the transcription initiation stage (controlled by the fold-change f and the Hill 
coefficient n in our model of transcriptional control) is usually quite limited. It is thus crucial to 
harness cooperativity from the other processes involved in the operation of gene circuits. A 
simple and direct source of cooperativity that does not involve additional genes and proteins is 
the nonlinearity in TF dimerization. In order to harness this cooperativity, however, it is 
necessary to maintain the cellular TF level at or below the dimer dissociation constant . This 
would leave the system with two undesirable options: Either use typical dimeric TFs with 
nM and maintain the TFs at a very low level (e.g., below 10 molecules per cell) which 
leaves the system vulnerable to stochastic fluctuations, or use TFs with large  to maintain a 
higher TF level (e.g., ~100 nM) to reduce these fluctuations, but expose the system to an 
increased load of nonfunctional monomers. We have shown that cooperative stability removes 
the link between the cellular TF levels and the  values. This makes it possible to 
simultaneously maintain a cellular TF level that is robust to fluctuations and allow the circuit to 
Kd




harness dimer cooperativity for the typical (strong) dimers; the latter relieves the system of the 
monomer load problem. 
Importantly, cooperative stability has broadened the parameter space for desired circuit 
operations, so that these circuits may be put together using typical components (TFs and 
promoters) without resorting to rare components with extreme properties. We suggest that this 
broadening of the operable parameter space is not only useful in relaxing the design constraints 
in synthetic biology experiments, but is moreover crucial for such circuits to emerge from natural 
evolution: Evolvability of a circuit requires that before selection can exert any effect, it should be 
possible for the organism to spontaneously assemble a primitive circuit that can sustain some 
rudimentary operation conferring some limited fitness advantage (41). This possibility is much 
enhanced if the circuit can operate using components widely accessible to the cells.  Of course, 
cooperative stability is not the only strategy to boost the degree of cooperativity needed for 
circuit operations. There exist alternative strategies which may provide stronger cooperativity, 
including nonlinear feedback at the level of transcriptional and translational 
initiation/termination as well as proteolytic control involving post-translational modifications. 
However, such processes require additional genes and proteins. They may be the final outcome 
of extended refinement of genetic circuits through a prolonged evolutionary process. In contrast, 
cooperative stability does not require any additional molecular components except for the 
dimeric protein itself. Moreover, as we will argue below, cooperative stability is itself a readily 
evolvable molecular trait for typical dimeric proteins. Therefore, it may be used at early stages of 
evolution to provide a circuit with some rudimentary functions beneficial to the host, so that 
selection can begin to exert some effect.  
It is also interesting to note that for the genetic circuits studied, cooperative stability should 
result in an increase in the robustness of circuit function to stochastic environmental fluctuations 
as well as an increase in the operational parameter space. The latter will make the circuit more 
robust to mutational perturbations. The correlation between robustness against environmental 
and genetic perturbations, known as “congruence”, has been proposed on general theoretical 
ground (42, 43) but lacks direct experimental studies. Cooperative stability might provide a 
concrete molecular system to study such phenomena. Conversely, congruence implies that 
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selection for the robustness of circuit function would naturally favor the use of proteins with 
cooperative stability due to the enhanced evolvability of the resulting circuit.  
Molecular mechanisms for cooperative stability 
It remains to address how broadly cooperative stability may occur in nature, or alternatively 
put, how readily can cooperative stability be implemented molecularly if needed. We already 
mentioned in the Introduction a number of specific examples where oligomerization provides 
protection against degradation. A recently characterized example involving homodimeric 
bacterial TF is TraR, a LuxR-family regulator whose homodimerization appears to require the 
autoinduer AI (44,45). Concomitantly, TraR is found to degrade rapidly in vivo in the absence of 
the AI, but is stabilized (with over 30x longer half-life) in the presence of the AI (44). Here we 
suggest that TraR is just one example of a large class of proteins that are prone to exhibit 
cooperative stability.  
We note that many regulatory proteins are natively unfolded, and become folded and 
thermally stable only upon association with their targets (46). These include dimeric TFs which 
only fold upon dimerization and are referred to as “two-state dimers”  (47). The best studied 
among this class of proteins is the Arc repressor of phage P22 (26). As have been recently 
characterized (48,49), conspicuous molecular features of these two-state dimers include the large 
number of inter-monomer contacts (compared to intra-monomer contacts) and the 
hydrophobicity of the interfacial contacts. We conjecture that the two-state dimers are ideal 
molecules for cooperative stability. First, unfolded monomers are generally believed to be more 
susceptible to generic degradation (10,11). Second, their exposed hydrophobic surface patches 
can be targeted by various proteases (33). Thus, disordered monomers may be an elegant way for 
nature to keep the LOW state low, while not disturbing the stable oligomers in the HIGH state.  
The existence of a substantial number of two-state dimers suggests that these molecules may 
be readily obtained evolutionarily should they be needed. This is supported by recent 
experiments where upon deletion of a few residues at the end of the peptide, stably folded 
proteins can easily become natively unfolded (i.e., unfolded by itself), yet still fold upon target 
presentation (K. Plaxco, personal communication). This finding is consistent with the 
expectation that peptide termini away from the interaction surface contribute toward the stability 
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of the monomers but not the complex. Together with our conjectured relation between two-state 
dimers and cooperative stability, it suggests that the degree of cooperative stability of dimeric 
proteins is readily tunable by simple terminal deletions. Thus, two-state dimers might be the 
favorite component of evolution to assemble gene circuits or other regulatory systems.  
Ramifications for experiment and modeling 
Cooperative stability (i.e.,
 
) has certainly been used previously in genetic circuit 
modeling, both in oscillators and bistable switches. In Drosophila, reduced protein degradation 
by multimerization has been suggested to play a significant role in the genetic circuit controlling 
circadian rhythm (50,51). In the modeling of phage λ’s lysis/lysogeny system, cooperative 
stability was implicitly used but not always in consistent ways. For example, in their modeling of 
entry to lysogeny, Arkin et al (52) assumed that CI monomers were degraded with half-life of 
~15 min, and Cro monomers were degraded with half-life of ~ 5 min, while leaving the long-
lived dimers to dilution by cell growth. With a cell doubling time of ~30-50 min, these 
assumptions implicitly invoke cooperative stability with  for CI and 
λ p1 > λ p2
λp1 / λp2 ≈ 2 − 3
λp1 / λp2 ≈ 6 − 10  for Cro. On the other hand, in their analysis of the experimental results of 
Little et al (53) [on the robustness of lysogeny to changes in the affinity of the CI-operator 
binding], Aurell et al (54) and Zhu et al (55) assumed that monomers and dimers were degraded 
with equal rates. These authors concluded that additional source(s) of cooperativity are needed to 
explain the observed robustness. While the recent discovery of CI octamerization at PRM may 
provide some of the necessary cooperativity (1,56,57), we suggest that cooperative stability 
might be another possible source of cooperativity that needs to be examined critically. In fact, 
Reinitz & Vaisnys (58) had speculated long ago that concentration-dependent degradation of Cro 
(as suggested by the data of Pakula & Sauer (59)) might provide some of the cooperativity 
needed to reconcile the discrepancies between theory and experiment.  Given the strong impact 
that even a modest degree of cooperative stability can make on the phase diagram and the circuit 
stability (see Figs. 4 and 5), knowledge of the monomer/dimer turnover rates is crucial to guide 
quantitative studies of the  λ-switch and to help resolve puzzles regarding the stability and 
robustness of lysogeny.  
14 
More generally, we note that in the current genetic circuit modeling literature, the lack of 
attention paid to monomer/dimer degradation has resulted in various models being 
unintentionally locked into forms that assume either no cooperative stability (i.e., λp1 = λp2 ) or 
extreme cooperative stability (i.e., λp2 = 0 ). We hope that our demonstration of the large impact 
of cooperative stability on circuit operation will motivate the modeling community to be more 
attentive to the quantitative treatment of degradation in future studies. On the experimental side, 
the addition of ssrA-tag on proteins has been widely used to control the turnover rate and hence 
the time scale of synthetic genetic circuits (14,60,61). However, depending on the degradation 
mode of the ssrA-tagged proteins (e.g., whether the monomers are preferentially degraded, or 
whether the turnover of both monomers and dimers are equally enhanced), ssrA-tagging could 
produce unexpected effects on the function of the circuits.  
Clearly, cooperative stability needs to be investigated quantitatively in the context of specific 
transcriptional systems in order to establish the extent this mechanism is used in nature. Here we 
stress that the ubiquity of molecules (i.e., the two-state dimers) with potential for cooperative 
stability and the magnitude of impact this effect can exert on the operation of genetic circuits 
make it necessary to characterize and address its possible effects systematically in any 
experimental or theoretical study of genetic circuits. The generic effect of cooperative stability 
described here, e.g., in reducing the basal level of active proteins and consequently amplifying 
control signals, provides a striking example of how biophysical properties at the molecular scale 
can directly impact high-level function of biomolecular networks. The effect is not limited to the 
nonlinear degradation of dimeric transcription factors or to the specific context of genetic 
circuits. We expect similar nonlinear effects to extend to protein modifications in signaling 
networks and co-regulated components of multimeric protein complexes. 
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Table 1: Summary of important parameters in our model together with their typical in vivo 
values in bacteria, and the principal molecular properties that determine their values. The entries 
shown in bold face refer to the parameters that are programmable over a wide range. The last 
column lists exemplary references for the indicated physiological parameter range. 
 
 description typical in vivo values principal molecular determinants references 
f  maximum fold-change  
in promoter activity 
10~100 (activator) 
10~1000(a)  (repressor) 
strength of TF-RNAp 
interaction (29,30) 
n cooperativity  
in promoter activity 1 ~ 2 
number of operator-bound 
TFs interacting with RNAp (31) 
κ   TF-operator  
dissociation constant 1~1000 nM
(b) operator sequence, binding 
interface of TF 
(23), and refs 
therein 
 λm−1  mRNA half-life ~ 5 min  (32) 
 
λ p−1  protein half-life  ~ 50 min (dilution) ~ few min (proteolysis) 
growth rate (dilution) 
protein stability,  
degradation tag (proteolysis)  
(4,33) 
γ   protein synthesis rate  
at full activation 0~100 nM/min
(c) ribosome binding site, 
transcriptional efficiency (24,34) 
Κd dimer dissociation 
constant ~ 10 nM 
(d) monomer-monomer  
affinity (25-28) 
                                                 
(a) Because repression involves TF-RNAp exclusion (a much stronger type of interaction than the weak attraction 
between RNAp and activators), the achievable fold-changes in repression can readily be much larger, 
e.g., . f ~ 1000
(b) The magnitude of κ   can be tuned by changing the number of bases matching the sequence for optimal TF-
operator binding; it is an example of programmable parameters which play important roles in natural evolution and 
synthetic design of promoters (3,23). 
(c) Another programmable parameter is γ through choice of the ribosome-binding site (RBS). Maximum protein 
synthesis rate is limited by the rate of elongation of the ribosome. In bacteria, the elongation rate of ribosome is ~20 
codons/sec and ribosomes occlude ~10 codons (34). Thus, the absolute maximum rate of protein synthesis per 
mRNA is ~120 proteins/min. Typical genes in bacteria have on average ~2 mRNA per cell (32), so that even with an 
optimal RBS, the maximum γ   is less than ~240 nM/min. For proteins that are diluted through cell division (~50 
mins), this range of γ produces steady-state protein concentrations of 0~10,000 nM. 
(d) A number of bacterial TFs, e.g., BlaI (35), FIS (27), and CopR (36) have  in the µM range. However, they are 
all “atypical” regulatory proteins whose in vivo concentrations in the active state exceed the order of 10 µM (35-37). 
However, it is generally believed that the over-expression of many TFs can be deleterious to the cells. For example, 
the maximum concentration for typical TFs in bacteria is not much more than ~100 nM; even the global regulator 
Crp is present only at ~1,500 nM (38). Thus, typical bacterial TFs tend to be at lower concentrations in vivo and tend 






Figure 1:  Two simple genetic circuits capable of (a) bistability and (b) oscillation. Genetic 
circuits consist of genes (drawn as circles) that regulate the transcriptional activity of one 
another. This regulation can be activating (arrow) or repressive (blunt line). Exemplary cis-
regulatory architectures in bacteria using (c) one or (d) two operator sites for activation, and 
using (e) one or (f) two operator sites for repression. The core promoter to which RNA 
polymerase (RNAp) binds and the operator sites to which the transcription factors (TF) bind are 
drawn as open or black boxes, respectively. The dashed lines depict cooperative interaction 
between regulatory proteins, whereas overlapping operators (indicated by dashed boxes) denote 




Figure 2:  Schematic diagram of the basic parameters involved in transcription, translation, 
degradation, and dimerization. Transcription is governed by the transcription rate α ⋅ g([TF ])  and α  is the mRNA synthesis rate at full activation. Each mRNA is translated into protein monomer 
at a rate ν, and degraded at a rate . The cellular concentrations of monomers ( ) and dimers 
( ) are related by the dimer dissociation constant . The protein degradation rate can be 








Figure 3:  Log-log plot of the relative promoter activity g([TF]) versus the transcription factor 
concentration [TF], for (a) activation and (b) repression. The general expression for the promoter 
activity function is written above each plot. The peak activity of a promoter is defined to be 1, 
the fold-change between LOW and HIGH plateaus is described by f, and the DNA-binding 
dissociation constant of a TF for its operator κ is the concentration which separates the HIGH 
plateau from the transition region. The log-log slope (s) of the transition region (referred to as 
“sensitivity” in the signal transduction literature (15)) quantifies the degree of cooperativity in 
transcriptional control. It is controlled by the Hill coefficient n and the maximum fold-change f, 
with maximum s approaching n for large f; see Supporting Information. Both (a) and (b) are 
approximations to promoter activity functions derived from detailed thermodynamic treatment of 




Figure 4: Quantitative characteristics of the bistable circuit with a single operator promoter 
( ) and a strong activator ( ). (a) Regime of bistability in the parameter space for the 
circuit with linear degradation (
n = 1 f = 100
λp1 λp2 = 1) and with cooperative stability ( λp1 λp2 > 1). The 
axes show combinations of the parameters which are both useful for the discussion and natural in 
the quantitative description, see Supporting Information. (b) For linear degradation, the steady-
state monomer (grey) and dimer (black) concentrations (i.e., and ) are plotted for 
different values of 
p1 * p2 *
κ , with  nM and (c)Kd = 10 Kd = 1000  nM, where γ  is chosen such that the 
system is in the middle of the bistable regime, i.e. the black band in (a), for each choice of 
and Kd κ . For both   and , the solid curve is the concentration in the HIGH state and the 
dashed curve is the concentration in the LOW state. (d) Same plot as (b) for the circuit with 
cooperative stability (
p1 * p2 *
λp1 λp2 = 10 ). 
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Figure 5: Quantitative characteristics of the three-gene oscillator involving repressor binding to 
a single operator site (n=1). (a) Oscillatory regime (shaded regions) in the parameter space for 
the case of linear degradation (λp1 = λp2 ) , using ={0.1,1} and f ={100,1000}, 
representing {typical, rare} values, respectively (with the same parameter combinations on the 
axes as in Fig. 4).  For 
 
λ p2 / λm
(λ p2 λm , f ) =(0.1,100), sustained oscillation is not possible within the 
physiological parameter range being shown. (b) For the circuit with cooperative 
stability
 
, we plot in the same parameter space the oscillatory regime with typical 
dimer/mRNA degradation rates (
 
= 0.1), at the fixed repression strengths  
(black) and  (grey). A significant part of the accessible parameter space now displays 
oscillatory behavior.  
(λp1 = 10λp2 )




Dimer dissociation constant in vitro and in vivo 
The dimer dissociation constant  is defined as the ratio of the concentrations of the 
monomers ( ) and dimers ( ) in steady state, i.e.,
Kd
p1 p2 Kd = p12 p2 . In terms of the basic kinetic 




(0) = kd ka . However, the effective value of Kd is modified in vivo due to a variety of 
processes, including those that change the rate constants k. Even if the rate constants do not 
change, Kd will also be affected by proteolysis or dilution, which alter the steady-state cellular 
protein concentrations. In the latter case, the combined effects of all these processes can be 










= −λp2 ⋅ p2 + ka p12 − kd p2  [S2] 
where γ is the protein synthesis rate and  ,  are the monomer, dimer degradation rates 
respectively; see the main text. The steady-state solution of Eq. S2 is ( , 
which according to the definition of the dissociation constant given above, yields an expression 
for the in vivo dissociation constant 
λp1 λp2










Note that the in vivo Kd is independent of , hence it does not depend on whether the 




S3, Kd is larger than the corresponding in vitro value .  Assuming that many dimers are 
diluted by cell division in the rapid exponential growth phase (~ 50 min half-life), then we can 
use typical monomer-monomer association rate of nM-min for small proteins (1, 2) to 





λ p2 ka to be ~ 0.3 nM.  Shifts of this 
magnitude in Kd are marginally relevant for typical TFs with nM, but they can become 
quite significant for larger proteins (e.g., enzymes) that have smaller k
Kd
(0) ~ 10
a or proteins that are 
rapidly degraded by proteolysis, see Table 1. 
 
Thermodynamic models of transcriptional control 




f −1 + [TF] κ( )n




1+ [TF] κ( )n f
1+ [TF] κ( )n  [S5] 
to describe the activities of the promoters shown in Fig. 1c-f. In this description, promoter 
activity is effectively characterized by three numbers, see Fig. 3: (i) f which defines the 
maximum fold-change in promoter activity, (ii) κ which indicates the concentration that 
separates the HIGH plateau from the transition region, and (iii) the “Hill coefficient” n which 
describes the transcriptional cooperativity in the transition region. Here, we use a more realistic 
description of the promoter activity based on the thermodynamic models of transcriptional 
initiation (3,4,5), and relate the effective parameters used in Eqs. S4 and S5 to the biochemical 
parameters controlling protein-DNA and protein-protein interactions.  We stress that our results 
which follow all implicitly presume that the promoters of interest are sufficiently weak (4,5).  
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Simple activation and repression. In the thermodynamic description, the promoter activity is 
assumed to be proportional to the equilibrium probability P that the RNA polymerase (RNAP) 
binds to the core promoter. The dependence of P on cellular TF concentrations (TF) for the four 
cis-regulatory architectures shown in Fig. 1 has been calculated elsewhere (4,5). The single 




1+ ω A− P ⋅[TF] / KA




Prep1([TF]) ∝ 11+ [TF] / KR
+ L  [S7] 
In the above equations, KA and KR refer to the dissociation constant between the TF and the 
respective operator sequence in vivo,  is the Boltzmann weight of the 
activator-RNAP interaction, and L describes the effect of “promoter leakage” in repression 
which is expected to occur even for  
ω A− P = exp(−∆GA− P / RT )
[TF ] → ∞ ‡. 
Since the effective promoter activity functions ( , ) shown in Eqs. S4 and S5 are simply 
, 
 
 normalized by their maximum values, one can compare Eqs. S4, S5 with S6, S7 to 
yield n=1 for both cases, with   and  for the activator, and   and  
for the repressor. An important feature of the promoter activity function in the context of genetic 
circuits is the sensitivity s, which is defined as the absolute value of the log-log slope of 
, i.e.,  
gA gR
 Pact1 Prep1










                                                 
‡ For instance, this may be due to the collision of the replication fork with the repressed promoter which occurs at 
least once per cell cycle. 
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They are plotted in Fig. S1a as a function of [TF ] / κ for different values of f=10, 100, 1000 for 
the activator and the repressor. Note that the maximum value of s , referred to here as s , 
occurs at the mid point of the transition region (see Fig. 3) and is strongly dependent on the 
magnitude of the fold-change f.  As shown in Fig. S1b, even at 
([TF ]) *
f = 100 , s*=0.82 is still below 
the theoretical maximum set by  . Since large f  is more readily available for repressors (due 
to the strong exclusion interaction between RNAP and the promoter-bound repressor), it is easier 
to attain large sensitivity using repressor-controlled promoters.   
n = 1
Cooperative activation. For the promoter shown in Fig. 1d involving two operators for the 
activator, the corresponding promoter occupancy probability (4,5) is: 
 
Pact 2([TF]) ∝
1+ [TF] / KH + ω A− P ⋅[TF] / K A + ω A− A ⋅ω A− P ⋅[TF]2 / (K A ⋅ KH )
1+ [TF] / K A + [TF] / KH + ω A− A ⋅[TF]2 / (K A ⋅ KH )
 [S10] 
where KH refers to the in vivo dissociation constant of the TF to upstream “helper” operator, and 
 is the Boltzmann weight associated with activator-activator interaction. The form (S10) is 
clearly different from the Hill form (S4), and the values of the effective Hill parameters n and κ 
will necessarily depend on the actual values of the parameters K
 ω A− A
A, KH, , and  .  In the 
main text, this promoter was used to model the P
ω A− P ω A− A
RM promoter of phage lambda studied 
experimentally by Issacs et al (6). For this case, the primary and helper activator sites are the 
operators OR2 and OR1 respectively whereas we neglected the very weak repressive site OR3 (7). 
The TF, lambda repressor protein CI, can stimulate transcription while bound at OR2§; the same 
TF can interact cooperatively with an adjacent TF bound upstream at O  (10).  R1
                                                 
§ The stimulation of transcription by TFs (i.e. activation) typically described in thermodynamic models involves the 
“thermodynamic recruitment” of RNAP by the activator via a mutual attractive interaction (8).  Transcriptional 
stimulation by CI involves instead catalyzing the rate of RNAP-promoter isomerization from a closed inactive form 
to an open active form (9). This change in isomerization rate, , is mathematically equivalent to 
“thermodynamic recruitment” with . 
∆kiso
ω A − P ≈ ∆kiso
29 
It is well known that the transcriptional stimulation provided by CI at PRM is weak, with 
 (9). The in vivo values of the CI-operator dissociation constants   and   are not 
known, but their ratio is expected to be equivalent to the ratio of the in vitro dissociation 
constants. The latter have been measured, together with the CI-CI affinity . There are two 
sets of parameter values commonly used in the phage lambda literature: (i) Shea & Ackers 
(1985) (3) where  
 ω A− P ≈ 11 K A KH
ω A− A
K A KH ≈ 17  and  , and (ii) Koblan & Ackers (1992) (11) where ω A− A ≈ 25
 K A KH ≈ 25  and  .  In Fig. S2a, we plot the function (normalized by its 
maximum value) against   for the two sets of parameters (the solid black and grey 
lines). The two curves are then fit to the effective Hill form (S4) to extract the effective 
parameters:   and  for SA85; and 
ω A− A ≈ 100 Pact 2
[TF ] / KH
n ≈ 1.53 κ ≈ 1.22KH n ≈ 1.69  and for KA92; see the 
dashed lines in Fig. S2a. In Fig. S2b, we plot the sensitivity function  for the two cases. 
We see that despite the improved Hill cooperativity for this promoter  (
κ ≈ 0.64KH
sA([TF ])
n ≈ 1.5 − 1.7 ), the 
marginal fold-change   in activation limits the maximum sensitivity to  . f = 11 sA* < 1
Dual repression. For the promoters controlled by two repressor sites (Fig. 1f), the corresponding 
activity function (4,5) is given by 
 
 
Prep2 ([TF]) ∝ 1(1+ [TF] / KR1) ⋅ (1+ [TF] / KR2 )
+ L  [S11] 
where KR1 and KR2 refer to the in vivo dissociation constants for the two operators, and L again 
describes promoter leakage. Examples of such cis-regulatory constructs are the very strongly 
repressively controlled promoters constructed by Lutz & Bujard (12) with very low leakiness. In 
Fig. S3a, we plot the relative activity function for , and KR1 = KR2 L = 10−3  (solid line). The 
dashed line is the best fit to the Hill form (S5), with the effective parameters 
, , and  . The sensitivity function  plays an important role in 
the ring-oscillator circuit (as will be shown below); it is plotted in Fig. S3b. Owing to the large f, 
 is in this case close to its maximal theoretical value set by the Hill coefficient  . 
 n = 1.63 κ ≈ 0.52KR1 f = L−1 sR ([TF ])
 sR
* n = 1.63
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Bistability  
This genetic circuit shown in Fig. 1a consists of a single gene, which encodes a protein that 
homodimerizes and activates its own transcription. The steady-state occurs when degradation 
















κ  [S12] 
where   is the steady-state TF dimer concentration. Given the form of the promoter activity 
function g
p2 *
A, the above equation can be solved to yield the stable solutions p2 * κ  as a function 
of the dimensionless, programmable parameters, γ κ ⋅ λ p2  and Kd κ  for different choices of 
 
λp1 λp2 . For the promoter containing a single operator site (Fig. 1c), is given by Eqn. 
S4 with   as discussed above. Solving Eqn. S12 using Mathematica 4.2 (13), we obtain 





 f = 100 λ p1 λp2 = 1,3,10 .  
The above procedure is repeated for the promoter with double operators (Fig. 1d) which we 
use as a model of the PRM promoter studied in the experiment of Issacs et al (6). The 
corresponding promoter activity function is  as sketched in Fig. S2a and described by the 
approximate Hill form (S4) with  and 
gA
f ≈ 11 n ≈ 1.7 . In Fig. S4, we again plot the bistable region 
in the space of the two programmable parameters (γ κ ⋅ λ p2 , Kd κ ) for λ p1 λ p2 = 1.  Despite 
the improved Hill coefficient for this promoter when compared to the single operator promoter 
discussed above, the regime of bistability for both cases are similarly limited (compare the black 
band in Fig. S4 and Fig. 4a). This is a consequence of the small fold-change (f) involved in auto-
activation of the PRM promoter studied by Isaacs et al. (6). 
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Oscillation  
For the repressillator circuit of Fig. 1b, we have 3 genes whose mRNA and (total) protein 
concentrations are denoted by   and  with m( i) p( i) i ∈{1,2,3}. An approximate picture of the 
circuit behavior can be obtained by assuming that the 3 genes have the same properties, e.g., the 
same promoter structure and the same synthesis/turnover rates (14). The circuit topology of Fig. 
1b then leads to the following kinetic equations 
 ( )( ) ( 1) ( )2  i iRd m g p mdt α −= − imλ  [S13] 
 (( ) ( ) ( )2  i id p m pdt ν= − ∆ )i  [S14] 
In Eq. S13, the promoter activity function gR p2
( i−1)( ) is given by Eq. S5 and the functional TFs 
are again dimers (of concentration  for each species i), with  completing the circuit 
loop. We assume rapid equilibration between the monomers and dimers, such that the dimer and 




  p = Kd ⋅ p2 + 2 p2  [S15] 
for each species. According to the spirit of our approximation, these dimers all have the same Kd. 
In Eq. S14, we introduced the protein degradation function 
 
 
∆ = λ p1 Kd ⋅ p2 + 2λ p2 p2  [S16] 
which gives the total protein degradation rate. 
To find the condition for oscillation for the system defined by Eqs. S13-S16, we follow the 
analysis of Elowitz (15) and first solve for the steady-state concentrations  
such that the left-hand side of Eqs. S13-S14 are zero. This is given by the condition 
( ) * ( ) *
2 2{ ,




γ ⋅ gR p2* / κ( )= ∆ p2*( ) [S17] 
where 
 
γ = α ⋅νλm
. We then analyze small perturbations about this steady state and find the 
condition where undamped oscillatory solutions emerge (16). This amounts to finding the purely 
imaginary eigenvalues of the following Jacobian **:  
  [S18] 
 
J =
−1 0 0 0 0 −x
1 − y 0 0 0 0
0 −x −1 0 0 0
0 0 1 − y 0 0
0 0 0 −x −1 0











dx g p p
dp
γ
λ= − ⋅ , ( )1 2 * ( )m p
dy p
dp
λ−= ⋅ ∆ p , and  is given by Eq. S15. 
The only acceptable solution of this system is given by the condition 
p2 ( p)
 ( )( )




+ = − y  [S19] 
which can be alternatively expressed as x y =ψ ( y)  where  
 
 










It is straightforward to show that the steady-state solution is stable whenever  x / y < ψ ( y) .  
Thus oscillation is not possible in this regime. For x / y > ψ ( y) , we verified that the system 
remains in an oscillatory state by direct numerical integration of the kinetic Eqs. S13 and S14. 
                                                 
** We have rewritten Eqs. S13-S14 where the mRNA concentration and time have been rescaled to m ⋅ν λm and 
t ⋅ λm . 
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The condition  x y =ψ ( y)  defines the boundary of the oscillatory phase. The function  ψ ( y)  is 
plotted in Fig. S5 and the oscillatory region is shaded. 
From the form of  ψ ( y) , it is clear that no oscillation is possible if .  For 
, oscillation will occur independently of y. For the intermediate range  
x / y < 4 / 3
 x / y > 2 4 / 3 < x / y < 2 , 
oscillation is most favorable for  , i.e. the minimum ofy ≈ 1 ψ ( y) . To interpret the physical 












d ln p2 p2*
is the sensitivity function, and r ≡ d ln ∆
d ln p2 p2*
 is the log-log slope of the 
degradation function defined in Eq. S16. Eq. S21 shows that the function (i.e. oscillation) of the 
circuit is intimately related to the sensitivity. Since 1 / 2 ≤ r ≤ 1, we conclude that oscillation will 
always occur if 
 
. However, this is hardly satisfied for typical promoters. On the other 
hand, we note that in the regime where 
sR p2
*( )> 2
r ≈ 1/ 2  (i.e., the degradation flux is predominantly 
through monomer loss), oscillation will always occur if sR p2
*( )> 1. This sensitivity is achievable 
by a promoter with two repressor sites (see Fig. S3b), but not for a promoter with a single 
repressor site since  (Fig. S1). For the latter promoter, oscillation can still occur if 
 and y is close to 1 (see Fig. S4). 
sR < n = 1
 
sR p2
*( )> 2 / 3





















                                                 
†† This relation can be derived starting from the definition of x and y, by applying the chain-rule of differentiation 
and invoking the steady-state condition (S17). 
34 




y = λp1 λm , and oscillation is most favorable in this regime if the mRNA and 
monomer degradation rates are comparable (where y ≈ 1). (ii) when  
(i.e. dimers are the dominant species, but degradative flux is still predominantly through the 
monomers), then 
 Kd = p2




* , and depending on the steady-state dimer concentration , y 















⎛ ⎞⎜ ⎟⎜ ⎟⎝ ⎠
 K  (dimers are the dominant 
species and degradative flux is predominantly through dimers), then y = λp2 λm .  From the 
above analysis, we see that cooperative stability (i.e., ) improves the condition for 
oscillation by increasing the regime where degradation flux is monomer dominated, so that a 
large regime of parameter space is governed by 
λp1 / λp2 > 1
r ≈ 1/ 2  and y ≈ 1. 
This is illustrated explicitly in Fig. 5, where we plot the region of spontaneous oscillation as a 
function of the programmable parameters (γ κ ⋅ λp2 , Kd κ ) for different fixed ( λp1 λp2 , 
 
λp2 λm ) using  for the promoter containing a single repressor site with   and 
. The contour of oscillatory parameter space shown in Fig. 5 was generated using 
Mathematica 4.2 (13) by first numerically solving Eq. S17 to obtain  for each set of 
parameters, then determining y and  according to their definitions, e.g., see Eq. S18, and 
finally comparing to the oscillatory condition 
gR n = 1




x / y > ψ ( y) .
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(0) (nM)  kd
−1  (min) ka
−1 (nM-min) Kd (nM) References 
Arc 10 0.2 2 10 (17) 
HIV-1 protease 4 8 32 4.5 (18) 
CRP 0.1-1 330 30 - 300 0.5 – 5 (19,20) 
β-galactosidase 0 0 3900 56 (21) 
 
Table 1: In vitro values for  ,  ,  were taken from the literature for a few exemplary 
cases.  Presuming that dimer “turnover” in vivo occurs primarily through dilution 
 
min, 
we can estimate the in vivo dimer dissociation constant . Note that two-state dimers such as 
the Arc repressor tend to have smaller  than the typical value given above ( nM-min), 
due presumably to the lack of orientation constraints in the association process (22). On the other 
hand, large proteins such as β-galactosidase will tend to have larger , which can lead to large 















Figure S1:  (a) Plot of the sensitivity for simple activation ( ) and repression ( ) at n=1 for 
different  .  The legend to these curves is located in the adjacent figure. (b) Plot 
of the maximum sensitivity ( ) as a function of promoter strength .  The shape of the curve 




n s * ) and whether the Hill 
function is repressive ( ) or activating ( ). gR gA
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Figure S2:  (A) Log-log plot of the promoter activity for the Isaacs promoter (6) (see Fig. 
1d) as a function of relative concentration [
Pact 2
TF ] KH using two different sets of experimental 
parameters: SA85 (3) and KA92 (11).  Each set of parameters is fit to , an approximate 
Hill function described in Eq. S4. We obtain: 
gA([TF ])
n ≈ 1.53 and for SA85; and  κ ≈ 1.22KH n ≈ 1.69  
and  for KA92 (B) The log-log slope of the activity function (the sensitivity ) as a 
function of relative protein concentration [
κ ≈ 0.64KH sA
TF ] KH is plotted for both sets of parameters for both 




Figure S3:  (A) Log-log plot of the promoter activity that describes the promoters 
engineered by Lutz et al. (12) (see Fig. 1f) as a function of relative concentration  
Prep2
[TF] KR1 using 
the experimental parameters   and KR1 = KR2 L = 10−3 . The promoter activity   is fit to 
, an approximate Hill function described in Eq. S5. We obtain parameters 
, . (B) The log-log slope (sensitivity ) of the promoter activity as a 
function of relative protein concentration [
Prep2
 gR ([TF ])
 n = 1.63 κ ≈ 0.52KR1 sR
TF] KR1  is plotted for and approximate Hill 






Figure S4:  The regime of bistability (shaded region) in the parameter space (
 
γ κ ⋅ λp2 , 
 Kd κ ) for linear degradation ( ) using the parameters λp1 = λp2 f = 11 ,  (see Fig. S2) 
that best describe the P
n = 1.7




Figure S5: Plot of  ψ ( y)  where the unstable solutions (oscillatory) that satisfy  x y > ψ ( y) are 
in the hatched region.  All  x y > 2 are oscillatory, independent of the relative rates of protein and 
mRNA degradation encapsulated by the parameter y .  
 
